Russia's Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials

In a breakthrough that reads like a beacon of hope, Russia has announced that its novel cancer vaccine, Enteromix, has demonstrated 100% efficacy and safety in initial human trials. The news highlights the vaccine's remarkable performance: patients experienced tumour shrinkage and no serious side effects. Developed using the same mRNA technology as the COVID-19 vaccines, Enteromix is designed to train the immune system to recognize and eliminate cancer cells, a safer, more intelligent alternative to traditional treatments like chemotherapy. This pioneering therapy is personalized for each colorectal cancer patient, offering a custom immunotherapy tailored to an individual's tumour profile. The...